We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
The global market for smart medical devices will increase at a compound annual growth rate of 14.6 percent through 2026, to a total of $286 billion in 2026 from $110 billion in 2019, according to an analysis by ResearchAndMarkets.com. Read More
Johnson & Johnson (J&J) plans to spin off its over-the-counter consumer products unit from its more lucrative prescription drugs and medical devices division, splitting itself into two publicly traded companies within the next 18 to 24 months. Read More
GE blamed flat margins for its healthcare segment on inflation and lower “life care solutions” equipment revenue associated with the company’s partnership with Ford to deliver ventilators to the Department of Health and Human Services. Read More
Australia’s Therapeutic Goods Administration (TGA) has offered advice to devicemakers in a new guidance about how to apply for consent to import, supply or export a medical device that doesn’t comply with the agency’s Essential Principles for safety and performance. Read More
Boston Scientific is expanding its portfolio of cardiac devices through its $1.75 billion purchase of Toronto, Canada-based Baylis Medical, which specializes in minimally invasive heart access products. Read More
Boston Scientific is expanding its thrombectomy device portfolio by purchasing Freemont, Calif.-based Devoro Medical and its promising Wolf platform. Read More
Device and diagnostics manufacturers can expect supply shortages and other problems due to the COVID-19 pandemic throughout the rest of this year and well into next year. Read More
The European Commission (EC) is still looking into whether Illumina’s decision to complete its $8 billion acquisition of Grail is in breach of EU merger regulations. Read More